626 E Whispering Oaks, Palatine, IL 60074
+1-224-678-1803 info@7newswire.com Book A Demo

DSH Group Energy Acquires Private Company Genetics LSP: Fernando Aguirre, Executive Vice Chairman of DHS Announced in Press Conference

7Newswire

WASHINGTON, DISTRICT OF COLUMBIA – June 21, 2021 – DHS Group, a leading private equity firm, announced today that DHS Energy has completed an acquisition of Genetics LSP, based in Boston, Massachusetts, specializes in the design and development of catheter-based

delivery systems for interventional medical devices and implants. LSP’s founder Peter Gilmore, a 15-year veteran of the contract design and development industry, will lead DHS’ design and development efforts as well as further expansion in the California market. LSP represents the sixth add-on acquisition since DHS Group invested in LSP in February 2018. The acquisition furthers the company’s strategy to build a market leader in precision micro-manufacturing and design of complex interventional medical devices and componentry. With the addition of LSP’s design and development capabilities, DHS Group aims to further accelerate product development cycles and help customers advance their innovative product concepts to market more quickly.

DHS Group made its initial investment in LSP in partnership with medical device industry executive Kendall Harrison. DHS Group initially partnered with John Taylor in April 2017 to pursue opportunities in the medical device sector, and the investment in LSP represented another example of how DHS Group executes StrategyTM. Since DHs Group’s investment, John Taylor has partnered with the LSP team, including CEO Jim Kilmore, to significantly grow the company’s revenue and EBITDA through organic growth and strategic add-on acquisitions.

Dana Jolson, Executive Chairman of LSP, commented, “Consistent with our initial investment thesis for DHs Group, the acquisition of LSP strategically enhances DHS Group’s capabilities, and further establishes the company’s position as a leading service provider to interventional medical device companies.”

Fernando Aguirre, Executive Vice Chairman of DHS, added, “We have great respect for what Dana and the LSP team has built, and we look forward to our partnership with them. This represents DHS Group’s sixth acquisition since our initial investment, and we expect to continue to aggressively pursue tuck-in acquisitions as well as more transformative opportunities.”

Lowland-Fuller provided legal counsel and KPMG served as accounting advisor to DHS Group.

ABOUT DHS

DHS is a high-stakes advocacy, public strategy, and global public relations and communications firm. Our strategic insights and innovative programming build and sustain strong corporate and brand reputations. We provide our clients with counsel and program development across the spectrum of public relations, public affairs, reputation and crisis management, digital strategy, advertising and other communications services. Our clients are companies, industry associations, nonprofit organizations, professional services firms, and other large organizations.

We began as a unique grassroots and lobbying firm with customized services for an elite group of clients. Our work applies equally to regulatory issues as well as legislative ones, and we manage issues for our clients at the local, state, federal, and international levels of government.

We use our core competencies and reach to gain competitive advantage for clients. Our expertise comes from extensive must-win campaign experience and operating successfully at the highest rung of business, government, politics and media. Our reach is the ability to use strategic intelligence to mobilize the message and persuade the toughest audiences. We know what it takes to win in difficult situations. We have proven results for prominent figures, leading advocacy groups and the world’s most successful companies. We leverage what others cannot.

DHS INVESTORS

This release contains forward-looking statements which are made pursuant to the safe harbor provisions of Section 27A of the Securities Act of 1933 and of Section 21E of the Securities Exchange Act of 1934. These forward-looking statements do not constitute guarantees of future performance. Those statements involve a number of factors that could cause actual results to differ materially, including risks associated with transitions in key personnel and succession, products, their development, integration and distribution, product demand and pipeline, customer acceptance of new products, economic and competitive factors, DHS’ key strategic relationships, acquisition and related integration risks as well as other risks detailed in DHS’ filings with the Securities and Exchange Commission. DHS assumes no obligation to update any forward-looking information contained in this press release or with respect to the announcements described herein.

DHS® is a trademark or registered trademark of DHS Investments, Inc. and/or one or more of its subsidiaries, and may be registered in the U.S. Patent and Trademark Office and in other countries. All other trademarks and registered trademarks are property of their respective owner.

CONTACT
Steven Palmer, Vice President of Communications
DHS Group
202-719-0398
s.palmer@dhs-grp.co